These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33883739)

  • 21. Enhancing the WHO's Proposed Framework for Distributing COVID-19 Vaccines Among Countries.
    Emanuel EJ; Luna F; Schaefer GO; Tan KC; Wolff J
    Am J Public Health; 2021 Mar; 111(3):371-373. PubMed ID: 33566663
    [No Abstract]   [Full Text] [Related]  

  • 22. Win-win interactions between the public and private sectors.
    Batson A
    Nat Med; 1998 May; 4(5 Suppl):487-91. PubMed ID: 9585192
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 24. Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers.
    Kartoglu UH; Moore KL; Lloyd JS
    Vaccine; 2020 Jul; 38(34):5393-5395. PubMed ID: 32600910
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of 2020 through Nature's editorials.
    Nature; 2020 Dec; 588(7839):537-538. PubMed ID: 33353979
    [No Abstract]   [Full Text] [Related]  

  • 26. Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.
    Rogers AB; Barrie MB; Fallah MP; Kelly JD
    Am J Trop Med Hyg; 2021 Jun; 105(2):278-280. PubMed ID: 34181573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. World Bank speeds Africa's COVID vaccination.
    Walsh C
    Nature; 2022 Apr; 604(7907):625. PubMed ID: 35474530
    [No Abstract]   [Full Text] [Related]  

  • 28. [The Saga of Vaccines against Covid-19].
    Saliou P
    Bull Soc Pathol Exot; 2020; 113(4):185-186. PubMed ID: 33826275
    [No Abstract]   [Full Text] [Related]  

  • 29. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19: LMICs need antivirals as well as vaccines.
    Bajaj SS; Stanford FC
    Nature; 2022 Feb; 602(7895):33. PubMed ID: 35105995
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19 vaccines: how to ensure Africa has access.
    Nkengasong JN; Ndembi N; Tshangela A; Raji T
    Nature; 2020 Oct; 586(7828):197-199. PubMed ID: 33024330
    [No Abstract]   [Full Text] [Related]  

  • 32. Covid-19 vaccine passports: access, equity, and ethics.
    Osama T; Razai MS; Majeed A
    BMJ; 2021 Apr; 373():n861. PubMed ID: 33795260
    [No Abstract]   [Full Text] [Related]  

  • 33. Pool patents to get COVID vaccines and drugs to all.
    Billette de Villemeur E; Dequiedt V; Versaevel B
    Nature; 2021 Mar; 591(7851):529. PubMed ID: 33742180
    [No Abstract]   [Full Text] [Related]  

  • 34. To curb COVID-19, global health must go local.
    Nat Med; 2021 Jun; 27(6):929. PubMed ID: 34031608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. South African scientists copy Moderna's COVID vaccine.
    Maxmen A
    Nature; 2022 Feb; 602(7897):372-373. PubMed ID: 35115696
    [No Abstract]   [Full Text] [Related]  

  • 36. Licensing IP to ensure accessibility to vaccines and other immunisation-related products.
    Mehta JM
    Vaccine; 2001 Feb; 19(13-14):1581-7; discussion 1592-3. PubMed ID: 11166878
    [No Abstract]   [Full Text] [Related]  

  • 37. A matter of priority: equitable access to COVID-19 vaccines.
    Holzer F; Luna F; Manriquez T; Biller-Andorno N
    Swiss Med Wkly; 2021 Mar; 151():w20488. PubMed ID: 33715145
    [No Abstract]   [Full Text] [Related]  

  • 38. Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective.
    McAdams D; McDade KK; Ogbuoji O; Johnson M; Dixit S; Yamey G
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33257418
    [No Abstract]   [Full Text] [Related]  

  • 39. Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.
    Kavanagh MM; Gostin LO; Sunder M
    JAMA; 2021 Jul; 326(3):219-220. PubMed ID: 34196659
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19 vaccines pricing policy options for low-income and middle- income countries.
    Guzman J; Hafner T; Maiga LA; Giedion U
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33727281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.